{
    "code": "02025899",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025899",
    "time": "2019-12-13 03:38:20",
    "許可證字號": "衛署藥輸字第025899號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/03\/18",
    "發證日期": "102\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202589903",
    "中文品名": "健仕平&quot;山德士&quot;40毫克\/毫升注射劑",
    "英文品名": "Gemcitabine Sandoz 40mg\/ml Concentrate for Solution for Infusion",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌。GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。膽道癌。",
    "劑型": "270注射劑",
    "包裝": "5ml, 25ml, 50ml瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1422701100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "1437920300  臺灣神隆股份有限公司",
            "製造廠廠址": "台南市善化區台南科學園區南科八路１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FIL0021000  TEVA GROUP",
            "製造廠廠址": "PLANTEX LTD, 1 HAKADAR STREET, INDUSTRIAL ZONE, ISRAEL-421 01 NETANYA",
            "製造廠公司地址": "",
            "製造廠國別": "ISRAEL",
            "製程": ""
        },
        {
            "製造廠名稱": "FIN0361100  DR. REDDY&#39;S LABORATORIES LIMITED",
            "製造廠廠址": "PLOT NO. 137, 138&amp;146 SRI VENKATESWARA CO-OPERATIVE INDRUSTRIAL ESTATE I.D.A. BOLLARAM, JINNARAM MANDAL, INDIA-502 325 MEDAK DISTRICT, ANDHRA PRADESH",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(corresponding to 40mg Gemcitabine)",
            "含量": "45.5600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Gemcitabine_Bottle-105-12-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025899&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "健仕平40毫克毫升注射劑-仿單-107-12-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025899&Seq=003&Type=9"
        },
        {
            "title": "Gemcitabine_FB-105-12-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025899&Seq=008&Type=8"
        }
    ]
}